PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress PYPD Q1 2026 Earnings EPS Beat on Operational Discipline But Revenue Remains Absent OGEN Q2 2023 Earnings Significant EPS Beat Highlights Cost Management Progress TXO Partners LP Q1 2026 Earnings Deep Loss Per Unit Fails to Deter Investors Stock Gains 393 ARMK Q1 2026 Earnings Earnings Slightly Miss Estimates Amid Operational Improvements